Novel cerebral lesions in the Eker rat model of tuberous sclerosis: Cortical tuber and anaplastic ganglioglioma

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 3, 2000, Pages 188-196

  Mizuguchi, Masashi ^a   Takashima, Sachio ^b   Yamanouchi, Hideo ^c   Nakazato, Yoichi ^c   Mitani, Hideaki ^d   Hino, Okio ^d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b National Center of Neurology and Psychiatry   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d CANCER INSTITUTE   (Japan)

Author keywords

Animal model; Cortical tuber; Eker rat; Ganglioglioma; TSC2; Tuberin; Tuberous sclerosis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOMA; BRAIN INJURY; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GLIOMA; IMMUNOHISTOCHEMISTRY; NONHUMAN; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; RAT; SUBEPENDYMOMA; TUBEROUS SCLEROSIS;

EID: 0034095926     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.3.188     Document Type: Article

References (43)

1. Bender BL, Yunis EJ. The pathology of tuberous sclerosis. Pathol Annu 1982;17:339-82
2. Bjornsson JB, Short MR Kwiatkowski DJ, Henske EP. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol 1996;149:1201-8
3. Mizuguchi M, Yamanouchi H, Takashima S. Neurological aspects of tuberous sclerosis. In: Niimura M, Otsuka F, Okio H, eds. Phacomatosis in Japan. Epidemiology, clinical picture, and molecular biology. Tokyo: Japan Scientific Societic Press, 1999:61-71
4. Fryer AE, Chalmers A, Connor JM, et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987;1:659-61
5. Kandt RS, Haines JL, Smith M, et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992;2:37-41
6. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-8
7. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-15
8. Plank TL, Yeung RS, Henske EP. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998;58:4766-70
9. van Slegtenhorst M, Nellist M, Nagelkerken B, et al. Interaction between hamartin and tuberin, the TSC1/ and TSC2 gene products. Hum Mol Genet 1998;7:1053-57
10. Kerfoot C, Wienecke R, Menchine M. et al. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol 1996;6:367-77
11. Menchine M, Emelin JK, Mischel PS, et al. Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues. Mod Pathol 1996;9:1071-80
12. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol 1996;40:941-44
13. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol 1997;94:525-31
14. Henske EP, Wessner LL, Golden J, et al. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol 1997;151:1639-47
15. Wienecke RW, Maize JC Jr, Reed JA, de Gunzburg J, Yeung RS, DeClue JE. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol 1997;150:43-50
16. Kimura N, Watanabe M, Date F, et al. HMB-45 and tuberin in hamartomas associated with tuberous sclerosis. Mod Pathol 1997;10:952-59
17. Johnson MW, Emelin JK, Park S-H, Vinters HV. Colocalization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis. Brain Pathol 1999;9:45-54
18. Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O. A germ-line insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet 1995;9: 70-74
19. Hino O, Klein-Szanto AJP, Freed JJ, et al. Spontaneous and radiation-induced renal tumors in the Eker rat model of inherited cancer. Proc Natl Acad Sci USA 1993;90:327-31
20. Everitt JI, Goldworthy TL, Wolf DC, Walker CL. Hereditary renal cell carcinoma in the Eker rat: A rodent familial cancer syndrome. J Urol 1992;148:1932-36
21. Yeung RS, Katsetos CD, Klein-Szanto A. Subependymal astrocytic hamartoma in the Eker rat model of tuberous sclerosis. Am J Pathol 1997;151:1477-86
22. Curatolo P, Cusmai R, Cortesi F, Chiron C, Jambaque I, Dulac O. Neuropsychiatric aspects of tuberous sclerosis. Ann NY Acad Sci 1991;615:8-16
23. Kawarada T, Miura N, Sugiyama T. Antibody against single-stranded DNA useful for detecting apoptotic cells recognizes hexadeoxynucleotides with various base sequences. J Biochem (Tokyo) 1998;123:492-98
24. Wienecke R, Konig A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap 1 GAP activity. J Biol Chem 1995;170:16409-14
25. Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem 1997;272:6097-6100
26. Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschlager M. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem 1997;272:29301-8
27. Ito N, Rubin GM. Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 1999;96:529-39
28. Knudson AGJ. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-23
29. Wilson PJ, Ramesh V, Kristiansen A, et al. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum Molec Genet 1996;5:249-56
30. Au K-S, Rodriguez JA, Finch JL, et al. Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Am J Hum Genet 1998;62:286-94
31. van Slegtenhorst M, Verhoef S, Tempelaars A, et al. Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: No evidence for genotype-phenotype correlation. J Med Genet 1999;36:285-89
32. Jones AC, Shyamsundar MM, Thomas MW, et al. Comprehensive mutation analysis of TSC1 and TSC2 and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999;64: 1305-15
33. Kwiatkowska J, Jozwiak S, Hall F, et al. Comprehensive mutational analysis of the TSC1 gene: Observations on frequency of mutation, associated features, and nonpenetrance. Ann Hum Genet 1998;62: 277-85
34. Carbonara C, Longa L, Grosso E, et al. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 1994;3:1829-32
35. Green AJ, Johnson PH, Yates JR. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 1994;3:1833-34
36. Green AJ, Smith M, Yates JR. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 1994;6:193-96
37. Henske EP, Scheithauer BW, Short MP, et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 1996;59:400-406
38. Yamanouchi H, Jay V, Rutka JT, Takashima S, Becker LE. Evidence of abnormal differentiation in giant cells of tuberous sclerosis. Pediatr Neurol 1997;17:49-53
39. Fitz CR, Harwood-Nash DCF, Thompson JR. Neuroradiology of tuberous sclerosis in children. Radiology 1974;110:635-42
40. Padmaltha C, Harruff RC, Ganick D, Hafez GB. Glioblastoma multiforme with tuberous sclerosis. Report of a case. Arch Pathol Lab Med 1980;104:649-50
41. Hino O, Mitani H, Katsuyama H, Kubo Y. A novel cancer predisposition syndrome in the Eker rat model. Cancer Lett 1994;83:117-21
42. Crino PB, Trojanowski JQ, Dichter MA, Eberwine J. Embryonic neural markers in tuberous sclerosis: Single-cell molecular pathology. Proc Natl Acad Sci USA 1996;93:14152-57
43. Rennebeck G, Kleymenova EV, Anderson R, Yeung RY, Artzt K, Walker CL. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci USA 1998;95:15629-34